2）向外谋增长：网格化营销变革，飞入寻常百姓家 。公司正在稳步构建覆盖约3000万消费者 的市场网格化体系，覆盖了接近50%的省内人口。我们预计，随着种植与正畸业务推出面向下 沉市场的中低端产品，两大核心业务的增长动能有望全面释放。同时，伴随客群规模扩张与业务 协同效应形成良性循环，修复、大综合及儿科业务也有望受益。 根据《证券期货投资者适当性管理办法》及配套指引，本资料仅面向华创证券客户中的金融机构专业投资者，请勿对本 资料进行任何形式的转发。若您不是华创证券客户中的金融机构专业投资者，请勿订阅、接收或使用本资料中的信息。 本资料难以设置访问权限，若给您造成不便，敬请谅解。感谢您的理解与配合。 摘要 前言：沉舟侧畔千帆过，口腔医疗服务龙头再起航 。 2021年年中以来，通策医疗的股价经历了 一段长达四年的单边下行。这一轮深度回调，不仅是受市场流动性收紧导致的估值中枢下移影 响，其背后更反映了市场在政策不确定与宏观消费环境波动等因素冲击下，对口腔医疗行业原有 成长逻辑的质疑。站在当前时点，公司已在前所未有的压力测试后完成蜕变，正从过往高客单 价、高毛利的消费升级模式，向高效率、规模化和普惠性的品质医疗范式进行 ...

"我们坚信，德国的工业专长与中国市场活力和创新优势有效对接，将更好满足工业与消费领域的需 求。"卡斯滕·诺贝尔表示，汉高将持续在中国投资，与中国市场携手并进。 拜耳在华深耕140余年，中国已成为其全球最重要的战略支柱之一。拜耳集团首席执行官比尔·安德森表 示，中国在医学研究、现代科技领域展现出的全球领导力令人印象深刻，拜耳深表赞赏与敬佩。 新华社北京2月26日电 "多年来，德中两国始终保持着十分紧密的经贸联系，这为双方进一步深化合作 奠定了坚实基础""在当前充满挑战的时代背景下，稳定并进一步拓展双边经贸关系至关重要"…… 2月25日，北京人民大会堂，一场汇集西门子、大众、拜耳等知名德国企业代表的会晤在这里举行。随 德国总理默茨访华的德国经济代表团团长、德国联邦经济和能源部国务秘书斯特凡·鲁恩霍夫表示，期 待与中方在经贸领域持续深化互利共赢合作。 这支包含30位德国经济界代表的高级别代表团，成员来自汽车、化工、生物制药、机械制造、循环经济 等德国优势领域。外界评价，这般"高规格"，足以彰显德国企业对中国市场的高度重视，也传递出双方 深化务实合作的强烈意愿。 重视和青睐，并非凭空而来。近年来，中德贸易额保持在20 ...

阿通社2月12日消息，在迪拜举行的2026年世界健康博览会（WHX）上，"阿联酋健康"国家平台发 布"行为洞察人工智能平台"。该平台由阿联酋卫生和预防部（MoHAP）牵头实施，将整合人工智能、 行为科学与大数据分析技术，用于识别公众健康风险、优化干预措施和提升预防医学水平，推动医疗服 务向数字化、精准化转型，体现阿联酋以科技赋能公共卫生体系建设的战略方向。 （原标题："阿联酋健康"平台展示数字化举措） ...

Core Insights - The orthodontic industry is experiencing a dual drive from aesthetic economy and health necessities, with significant advancements in AI and consumer engagement [1][21] - The industry has evolved into a cross-sector involving high-end medical device manufacturing, digital healthcare services, and personalized consumption [1][21] Industry Chain Summary and Impact - The orthodontic industry chain is clearly defined, with a "smile curve" distribution, where the midstream digital treatment solution design and service platform is the core of value creation and profit center [3][22] - The upstream includes medical polymer materials (e.g., TPU, PETG for invisible aligners), metal alloys (brackets, archwires), digital equipment (intraoral scanners, CBCT, 3D printers), and design software suppliers [3][22] - The downstream consists of various dental service institutions, which are the final value realization and customer touchpoints, with changes in the downstream landscape influencing the upstream and midstream [3][22] Competitive Landscape - The current competition in the industry shows a distinct characteristic of "high concentration in midstream, decentralized but accelerating integration in downstream" [4][23] - The midstream invisible aligner solution market has formed a solid "duopoly" with Align Technology (Invisalign) and Angelalign dominating the market, holding a significant share [4][23] - The private market is represented by chain institutions like Tongce Medical and Ruier Group, which are expanding market share through standardized management and brand building [5][23] Technology Level and Characteristics - The industry is at a stage of comprehensive digitalization and burgeoning intelligence [6][24] - Digital technology has become the industry infrastructure, with 3D scanning replacing traditional silicone impressions, and CBCT widely used for three-dimensional assessments [7][25] - AI is rapidly penetrating and deepening its application, significantly enhancing design efficiency and reducing communication costs between doctors and technicians [8][26] Development Trends - AI is expected to evolve from "assisting" to "empowering" core functions, enhancing predictive capabilities and treatment plan adjustments [10][28] - The integration of treatment scenarios is expanding from "orthodontics" to "overall oral health management," creating new treatment combinations [11][29] - The trend towards affordability and market penetration is expected to activate a large incremental population, especially in lower-tier cities [12][30] - Leading companies are shifting from merely selling products to providing comprehensive solutions that enhance customer engagement and data value [13][31] - Chinese companies are accelerating their global expansion, establishing competitiveness in the digital orthodontics field [14][32]

Core Insights - The traditional healthcare system creates a "service gap" after patient discharge, particularly in oncology, where post-operative recovery and long-term support are often neglected [1] - As cancer is redefined as a manageable chronic disease, the industry is questioning whether healthcare services should remain confined within physical hospital walls [1] - Baize Medical (02609.HK) is implementing the H@H (Hospital At Home) model as a key strategy to extend healthcare services from "hospital-centric" to "continuous management" [1] Group 1: H@H Model - H@H is not merely an extension of traditional home care but represents a systematic upgrade in healthcare service models [3] - Unlike conventional home services focused on basic care, H@H enhances the "management, connection, and companionship" aspects of Baize's comprehensive service system [3] - The model shifts the responsibility of healthcare from just the hospitalization period to a more extended and continuous management of patient health [3] Group 2: Technological Infrastructure - The success of "medical at home" relies heavily on systematic, standardized, data-driven, and intelligent infrastructure [5] - Baize Medical's core advantage lies in its AI-ready digital infrastructure, which integrates real-world healthcare service needs [5] - The four-layer technology architecture allows for real-time data standardization and utilization, enabling proactive interventions in patient care [5] Group 3: Industry Shift - The emergence of H@H reflects a shift in the value orientation of oncology services, focusing on long-term quality of life and patient experience rather than just single treatment outcomes [7] - This transition is driven by changes in disease characteristics, demographic shifts, and evolving patient needs [7] - H@H signifies a profound paradigm shift in oncology care, where the boundaries of healthcare are redefined around the patient rather than physical structures [7]

Core Viewpoint - BFB HEALTH, formerly known as 财讯传媒集团, has officially rebranded as "BFB HEALTH," marking its position as the first publicly listed company in China's remote medical health management sector, with a market capitalization exceeding 1.2 billion HKD [1][3] Group 1: Company Overview - The rebranding ceremony took place in Bozhou, Anhui, which is recognized as the "World Capital of Traditional Chinese Medicine" [1] - BFB HEALTH's stock closed at 0.99 HKD, indicating strong market interest and confidence in the company's future [1] - The company plans to allocate 50% of its secondary market financing towards AI upgrades and new drug development, while the other 50% will focus on product iteration, brand building, and upgrading intelligent production lines [1][5] Group 2: Market Context - The National Healthcare Security Administration issued guidelines for remote surgical assistance pricing, paving the way for the commercialization of remote medical services [3] - The remote medical market in China has surpassed 100 billion CNY, with a compound annual growth rate of over 25% [8] - BFB HEALTH fills a gap in the market as the first dedicated player in the remote medical sector on the Hong Kong stock exchange, leveraging its regional advantages in traditional Chinese medicine [3][4] Group 3: Business Model and Strategy - BFB HEALTH's business model mirrors that of U.S. telehealth giant Hims & Hers, focusing on a closed-loop system of online diagnosis, product services, and health management [4] - The company employs a "1+N" strategy, utilizing a cross-border drug purchasing platform to support multiple independent brands, thereby addressing diverse health needs and creating competitive advantages [5] - BFB HEALTH aims to enhance user engagement through a subscription model, similar to Hims, which locks in long-term users and stabilizes cash flow [4] Group 4: Industry Impact - BFB HEALTH is set to drive digital transformation in the healthcare industry by utilizing digital channels and AI technology, thus improving service efficiency and accessibility [6] - The company promotes personalized health services, shifting the industry focus from product-driven to user-centered approaches [6] - As the first private enterprise listed in Bozhou, BFB HEALTH is expected to stimulate local economic growth and attract related businesses, enhancing the regional healthcare ecosystem [7]

Group 1 - The National Healthcare Security Administration has announced a plan to promote convenient payment methods such as facial recognition, QR code payments, mobile payments, and credit payments in medical settings, aiming to establish a convenient payment system for medical insurance within three years [1] - By 2026, the first pilot regions and designated medical institutions are expected to implement these payment methods, with full provincial coverage anticipated by 2027 and comprehensive promotion in eligible medical institutions by 2028 [1] - Desheng Technology Co., Ltd. claims that its "no-feeling payment" service aligns well with this policy, as the company accelerates the construction of an AI medical application ecosystem to support the digital and intelligent transformation of medical services [1] Group 2 - Desheng Technology's "no-feeling payment" project, developed in collaboration with Guangzhou Medical Insurance, won first prize in the 2025 National Smart Medical Insurance Competition [1]

Core Viewpoint - The Nanjing Hanmei Weiti Plastic Surgery Hospital project has officially commenced construction, marking a significant step in advancing high-quality medical services in Nanjing through foreign investment [1][10]. Group 1: Project Overview - The project is being fully funded by M&J Medical Group through Singapore's VITA Health Co., with a total investment of approximately $10 million [1]. - The hospital will cover an area of about 8,700 square meters and is planned to have 120 beds, supported by a professional medical team of around 250 members [1][6]. - The hospital aims to start operations in the first quarter of 2026, aligning with national policies that allow the establishment of wholly foreign-owned hospitals [1]. Group 2: Construction and Management - The project will adhere to strict clean surgical technical standards to ensure safety and traceability throughout the surgical process [3]. - A dual foundation of "system + data" will be established during the construction phase, aiming to meet international safety targets and integrate the hospital's information systems [3]. Group 3: Medical Focus and Services - The hospital will focus on three main specialties: fine plastic surgery for eyes and nose, breast reconstruction, and skin anti-aging treatments [6]. - It will implement a dual-track talent system, combining long-term training from Korean experts with standardized training for local teams [6]. - The first-year surgical volume is projected to reach 5,000 procedures, emphasizing safety, quality, and a digitalized patient experience [6]. Group 4: Collaboration and Future Goals - The project aims to establish long-term partnerships with medical institutions, research institutes, and industry partners to enhance discipline construction, quality management, and talent cultivation [10]. - The initiative supports the broader goals of building a high-standard medical service system in Nanjing, contributing to the city's health and beauty initiatives [10].

Core Insights - Medtronic has launched its first open day for arrhythmia patients at its digital healthcare innovation base in Beijing, showcasing the potential of digital healthcare in managing patients throughout their disease journey [1][3] Group 1: Innovation and Services - The Medtronic Beijing digital healthcare innovation base is the world's first thematic innovation space focused on medical science popularization and patient services, integrating technology display, education, patient interaction, and remote services since its opening in October 2025 [3] - The base features the Medtronic Museum, which houses the world's first battery-operated external pacemaker and presents the evolution of medical technology and future visions [3][4] - The "Medtronic Heart Manager" platform, which has over 150,000 registered users, offers a comprehensive service model that includes remote follow-up, health education, postoperative recovery guidance, and online community interaction [3][4] Group 2: Patient Engagement and Community - During the event, patients experienced the remote follow-up system of the "Medtronic Heart Manager," allowing easy data upload via mobile devices, with real-time feedback from healthcare professionals [4] - The establishment of the "Medtronic Heart Health Club" aims to extend the online community to offline interactions, providing regular rehabilitation guidance, educational lectures, and social activities [4][5] - The club symbolizes a dedicated space for patients to connect and share experiences, enhancing the overall support ecosystem for arrhythmia patients [4][5] Group 3: Company Vision and Future Plans - Medtronic has been a leader in cardiac rhythm disease management for over 70 years, focusing on introducing advanced cardiac electronic implant devices and transforming services to enhance patient convenience [5] - The combination of the physical innovation base and the "Medtronic Heart Manager" platform creates a patient care system that emphasizes both technological precision and human warmth [5]

Core Insights - Baoji City has established a medical testing result sharing and recognition information platform, achieving cross-hospital usability for 101 testing items and serving 62,100 patients this year, saving 3.198 million yuan in testing costs [1][2] Group 1 - The platform was initiated to address issues of multiple tests and repeated examinations for patients visiting different medical institutions [1] - The platform standardizes testing report data across the city and enables real-time uploading and sharing of results, effectively breaking down data barriers between medical institutions [1] - As of now, the first phase of the project has connected 40 key medical institutions above the secondary level in the city [1] Group 2 - The platform includes common testing items such as blood routine, urine routine, liver function, and kidney function tests [1] - The Baoji City Health Commission plans to expand the range of institutions recognized by the platform and enhance its services, focusing on convenience for the public, assistance for medical professionals, and support for research [2]